Sitaram Ghogale
About
Sitaram Ghogale is a scholar working on Hematology, Public Health, Environmental and Occupational Health and Pathology and Forensic Medicine.
According to data from OpenAlex, Sitaram Ghogale has authored 29 papers receiving a total of 320 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Hematology, 16 papers in Public Health, Environmental and Occupational Health and 12 papers in Pathology and Forensic Medicine. Recurrent topics in Sitaram Ghogale's work include Acute Lymphoblastic Leukemia research (16 papers), Lymphoma Diagnosis and Treatment (12 papers) and Acute Myeloid Leukemia Research (9 papers). Sitaram Ghogale is often cited by papers focused on Acute Lymphoblastic Leukemia research (16 papers), Lymphoma Diagnosis and Treatment (12 papers) and Acute Myeloid Leukemia Research (9 papers). Sitaram Ghogale collaborates with scholars based in India. Sitaram Ghogale's co-authors include Prashant Tembhare, Papagudi Ganesan Subramanian, Yajamanam Badrinath, Sumeet Gujral, Nikhil Patkar, Gaurav Chatterjee, Nilesh Deshpande, Gaurav Narula, Shripad Banavali and Dhanalaxmi Shetty and has published in prestigious journals such as Blood, British Journal of Haematology and Frontiers in Oncology.
In The Last Decade
Sitaram Ghogale
27 papers receiving 312 citations
Peers
Sitaram Ghogale
Maaike de Bie Netherlands
Raouf Ben Abdelali France
Laura Key United States
Marzia Cavalli Italy
Lucia Anna De Novi Italy
Lüder Hinrich Meyer Germany
E. Björklund Sweden
Gabriele Körner Germany
C Rivas Spain
Sherry Pierce United States
Citations per year, relative to Sitaram Ghogale Sitaram Ghogale (= 1×)
peers
Maaike de Bie
Countries citing papers authored by Sitaram Ghogale
Since
Specialization
Citations
This map shows the geographic impact of Sitaram Ghogale's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sitaram Ghogale with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sitaram Ghogale more than expected).
Fields of papers citing papers by Sitaram Ghogale
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Sitaram Ghogale. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sitaram Ghogale. The network helps show where Sitaram Ghogale may publish in the future.
Co-authorship network of co-authors of Sitaram Ghogale
This figure shows the co-authorship network connecting the top 25 collaborators of Sitaram Ghogale. A scholar is included among the top collaborators of Sitaram Ghogale based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sitaram Ghogale. Sitaram Ghogale is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Ghogale, Sitaram, Nilesh Deshpande, Gaurav Chatterjee, et al.. (2024). Utility of leukocyte‐associated immunoglobulin‐like receptor‐1 (CD305 ) in flow cytometric detection of minimal bone marrow involvement by B ‐cell non‐Hodgkin lymphoma. Cytometry Part B Clinical Cytometry. 106(5). 359–369.
2.
Chatterjee, Gaurav, Sitaram Ghogale, Nilesh Deshpande, et al.. (2023). 15‐color highly sensitive flow cytometry assay for post anti‐CD19 targeted therapy (anti‐CD19‐CAR‐T and blinatumomab) measurable residual disease assessment in B‐lymphoblastic leukemia/lymphoma: Real‐world applicability and challenges. European Journal Of Haematology. 112(1). 122–136.
3.
Chatterjee, Gaurav, Salil Varma, Sitaram Ghogale, et al.. (2022). Clinical Utility Cytoplasmic TRBC1 Expression in the Diagnosis and Minimal Residual. Indian Journal of Medical and Paediatric Oncology. 43(S 01). S1–S19.
4.
Tembhare, Prashant, Gaurav Chatterjee, Sitaram Ghogale, et al.. (2022). Critical Role of Flow Cytometric Immunophenotyping in the Diagnosis, Subtyping, and Staging of T-Cell/NK-Cell Non-Hodgkin’s Lymphoma in Real-World Practice: A Study of 232 Cases From a Tertiary Cancer Center in India. Frontiers in Oncology. 12. 779230–779230.
5.
Ghogale, Sitaram, Nilesh Deshpande, Gaurav Chatterjee, et al.. (2022). Expression levels and patterns of B‐cell maturation antigen in newly diagnosed and relapsed multiple myeloma patients from Indian subcontinent. Cytometry Part B Clinical Cytometry. 102(6). 462–470.
6.
Chatterjee, Gaurav, Sitaram Ghogale, Nilesh Deshpande, et al.. (2021). Expression of CD304/neuropilin‐1 in adult b‐cell lymphoblastic leukemia/lymphoma and its utility for the measurable residual disease assessment. International Journal of Laboratory Hematology. 43(5). 990–999.
7.
Chatterjee, Gaurav, Sitaram Ghogale, Nilesh Deshpande, et al.. (2021). Mimics and artefacts of measurable residual disease in a highly sensitive multicolour flow cytometry assay for B‐lymphoblastic leukaemia/lymphoma: critical consideration for analysis of measurable residual disease. British Journal of Haematology. 196(2). 374–379.
8.
Deshpande, Nilesh, Prashant Tembhare, Syed K. Hasan, et al.. (2021). Improved protocol for plasma microRNA extraction and comparison of commercial kits. Biochemia Medica. 31(3). 467–475.
9.
Tembhare, Prashant, Gaurav Chatterjee, Sitaram Ghogale, et al.. (2020). Flow cytometric evaluation of CD38 expression levels in the newly diagnosed T-cell acute lymphoblastic leukemia and the effect of chemotherapy on its expression in measurable residual disease, refractory disease and relapsed disease: an implication for anti-CD38 immunotherapy. Journal for ImmunoTherapy of Cancer. 8(1). e000630–e000630.
10.
Tembhare, Prashant, Gaurav Narula, Sitaram Ghogale, et al.. (2020). Post-induction Measurable Residual Disease Using Multicolor Flow Cytometry Is Strongly Predictive of Inferior Clinical Outcome in the Real-Life Management of Childhood T-Cell Acute Lymphoblastic Leukemia: A Study of 256 Patients. Frontiers in Oncology. 10. 577–577.
11.
Chatterjee, Gaurav, Sitaram Ghogale, Yajamanam Badrinath, et al.. (2020). CD304/neuropilin‐1 is a very useful and dependable marker for the measurable residual disease assessment of B‐cell precursor acute lymphoblastic leukemia. Cytometry Part B Clinical Cytometry. 98(4). 328–335.
12.
Ghogale, Sitaram, Papagudi Ganesan Subramanian, Yajamanam Badrinath, et al.. (2019). Evaluation of CD319 (SLAMF7) as a Novel Gating Marker for Plasma Cells in Flow Cytometric Immunophenotyping of Multiple Myeloma. Clinical Lymphoma Myeloma & Leukemia. 19(10). e153–e153.
13.
Tembhare, Prashant, Gaurav Narula, Gaurav Chatterjee, et al.. (2019). Flow-Cytometry Based Detection of Any Minimal Residual Disease (FC-MRD) in Children with T-Acute Lymphoblastic Leukemias (T-ALL) Is a Powerful Indicator of Outcome. Blood. 134(Supplement_1). 2585–2585.
14.
Tembhare, Prashant, Papagudi Ganesan Subramanian, Sitaram Ghogale, et al.. (2019). A High‐Sensitivity 10‐Color Flow Cytometric Minimal Residual Disease Assay in B‐Lymphoblastic Leukemia/Lymphoma Can Easily Achieve the Sensitivity of 2‐in‐106and Is Superior to Standard Minimal Residual Disease Assay: A Study of 622 Patients. Cytometry Part B Clinical Cytometry. 98(1). 57–67.
15.
Ghogale, Sitaram, Papagudi Ganesan Subramanian, Nikhil Patkar, et al.. (2017). SLAM Family Member “CD229”: A Novel Gating Marker for Plasma Cells in Flow Cytometric Immunophenotyping (FCI) of Multiple Myeloma (MM). Clinical Lymphoma Myeloma & Leukemia. 17(1). e19–e19.
16.
Tembhare, Prashant, Yajamanam Badrinath, Sitaram Ghogale, & Papagudi Ganesan Subramanian. (2017). Method for DNA Ploidy Analysis Along with Immunophenotyping for Rare Populations in a Sample using FxCycle Violet. Current Protocols in Cytometry. 80(1). 6.38.1–6.38.15.
17.
Bibi, Asma, Nikhil Patkar, Papagudi Ganesan Subramanian, et al.. (2016). CD19 negative precursor B acute lymphoblastic leukemia (B‐ALL)—Immunophenotypic challenges in diagnosis and monitoring: A study of three cases. Cytometry Part B Clinical Cytometry. 92(4). 315–318.
18.
Rahman, Khaliqur, Neha Mittal, Sitaram Ghogale, et al.. (2012). Morphological spectrum of leukemic mantle cell lymphoma. Indian Journal of Pathology and Microbiology. 55(1). 66–66.
19.
Badrinath, Yajamanam, Prashant Tembhare, Papagudi Ganesan Subramanian, et al.. (2010). Comparison of platelet counts by CellDyn Sapphire (Abbot Diagnostics), LH750 (Beckman Coulter), ReaPanThrombo immunoplatelet method (ReaMetrix), and the international flow reference method, in thrombocytopenic blood samples. Cytometry Part B Clinical Cytometry. 78B(4). 279–285.
20.
Subramanian, Papagudi Ganesan, Ashok Kumar, Yajamanam Badrinath, et al.. (2010). Diagnostic Utility of CD200 and CD43 Co-Expression by Flow Cytometry In Differentiating Chronic Lymphocytic Lymphoma From Other of Mature B Cell Non Hodgkin's Lymphoma.. Blood. 116(21). 4615–4615.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Maaike de Bie Breakdown of academic impact, for papers by Raouf Ben Abdelali Breakdown of academic impact, for papers by Laura Key Breakdown of academic impact, for papers by Marzia Cavalli Breakdown of academic impact, for papers by Lucia Anna De Novi Breakdown of academic impact, for papers by Lüder Hinrich Meyer Breakdown of academic impact, for papers by E. Björklund Breakdown of academic impact, for papers by Gabriele Körner Breakdown of academic impact, for papers by C Rivas Breakdown of academic impact, for papers by Sherry Pierce